SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950142-21-003867
Filing Date
2021-12-02
Accepted
2021-12-02 17:17:01
Documents
13
Period of Report
2021-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh210206812_8k.htm   iXBRL 8-K 27042
2 EXHIBIT 10.1 eh210206812_ex1001.htm EX-10.1 52062
  Complete submission text file 0000950142-21-003867.txt   267239

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vtvt-20211201.xsd EX-101.SCH 3046
4 XBRL LABEL FILE vtvt-20211201_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE vtvt-20211201_pre.xml EX-101.PRE 22373
6 EXTRACTED XBRL INSTANCE DOCUMENT eh210206812_8k_htm.xml XML 3610
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 211467776
SIC: 2834 Pharmaceutical Preparations